The natural history of drug resistant epilepsy: epidemiologic considerations
- PMID: 1418457
The natural history of drug resistant epilepsy: epidemiologic considerations
Abstract
Approximately 160,000 United States residents will be evaluated for newly identified unproved seizures in 1990. While the majority will have a favorable prognosis and more than 50% will ultimately be able to discontinue medication, about 10,000 will fall into the category 'intractable'. There are well established predictors for seizure remission and for successful withdrawal of medications, including seizure type, etiology, age at onset, neurologic status, and family history. There are few studies which have evaluated predictors for poor outcome, in part because of difficulties with definition. Predictors of poor outcome are not necessarily the converse of predictors of good outcome. Identification of such factors is important to allow earlier referral of patients destined to meet criteria for intractable to allow alternative therapies to be instituted.
Similar articles
-
Discontinuing antiepileptic drugs in children with epilepsy: a prospective study.Ann Neurol. 1994 May;35(5):534-45. doi: 10.1002/ana.410350506. Ann Neurol. 1994. PMID: 8179299
-
Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy.Epilepsy Res Suppl. 1996;11:17-43. Epilepsy Res Suppl. 1996. PMID: 9294726 Review. No abstract available.
-
Long-term outcome of epilepsy.Epileptic Disord. 2000 Jun;2(2):79-88. Epileptic Disord. 2000. PMID: 10954238 Review.
-
Four-year outcome after early withdrawal of antiepileptic drugs in childhood epilepsy.Neurology. 2005 Jun 28;64(12):2136-8. doi: 10.1212/01.WNL.0000166035.26217.61. Neurology. 2005. PMID: 15985589 Clinical Trial.
-
Childhood absence epilepsy requiring more than one medication for seizure control.Can J Neurol Sci. 2008 Jul;35(3):297-300. Can J Neurol Sci. 2008. PMID: 18714796
Cited by
-
Laser ablation as treatment strategy for medically refractory dominant insular epilepsy: therapeutic and functional considerations.Stereotact Funct Neurosurg. 2014;92(6):397-404. doi: 10.1159/000366001. Epub 2014 Oct 29. Stereotact Funct Neurosurg. 2014. PMID: 25359500 Free PMC article.
-
Advances in neuroimaging: non-substrate-directed partial epilepsy.Curr Neurol Neurosci Rep. 2001 Jul;1(4):361-8. doi: 10.1007/s11910-001-0091-x. Curr Neurol Neurosci Rep. 2001. PMID: 11898543 Review.
-
Surgical Treatment for Extratemporal Epilepsy.Curr Treat Options Neurol. 2004 May;6(3):257-262. doi: 10.1007/s11940-004-0017-4. Curr Treat Options Neurol. 2004. PMID: 15043808
-
Presurgical evaluation and surgical treatment of medically refractory epilepsy.Neurosurg Rev. 2004 Jan;27(1):1-18; discussion 19-21. doi: 10.1007/s10143-003-0305-6. Epub 2003 Oct 28. Neurosurg Rev. 2004. PMID: 14586764 Review.
-
The Perineuronal 'Safety' Net? Perineuronal Net Abnormalities in Neurological Disorders.Front Mol Neurosci. 2018 Aug 3;11:270. doi: 10.3389/fnmol.2018.00270. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30123106 Free PMC article. Review.